These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10954662)

  • 41. [Methods for treating various forms of acne in the years 1991-2000, Department of Dermatology, Silesian Medical School].
    Bergler-Czop B; Brzezińska-Wcisło L
    Wiad Lek; 2005; 58(3-4):156-60. PubMed ID: 16119156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action.
    Hörfelt C; Stenquist B; Larkö O; Faergemann J; Wennberg AM
    Acta Derm Venereol; 2007; 87(4):325-9. PubMed ID: 17598035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris.
    Thiboutot D
    J Drugs Dermatol; 2008 Jan; 7(1):13-6. PubMed ID: 18246693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
    Plovanich M; Weng QY; Mostaghimi A
    JAMA Dermatol; 2015 Sep; 151(9):941-4. PubMed ID: 25796182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
    Liu A; Yang DJ; Gerhardstein PC; Hsu S
    J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Azoulay L; Oraichi D; Bérard A
    Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    de Resende MM; Kriegel AJ; Greene AS
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormonal treatment of acne: review of current best evidence.
    Tan J
    J Cutan Med Surg; 2004; 8 Suppl 4():11-5. PubMed ID: 15778821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profile of acne patients in the Philippines requiring a second course of oral isotretinoin.
    Haryati I; Jacinto SS
    Int J Dermatol; 2005 Dec; 44(12):999-1001. PubMed ID: 16409263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acne in the adult female patient: a practical approach.
    Kamangar F; Shinkai K
    Int J Dermatol; 2012 Oct; 51(10):1162-74. PubMed ID: 22994662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.
    Grandhi R; Alikhan A
    Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone.
    Barbieri JS; Margolis DJ; Mostaghimi A
    JAMA Dermatol; 2021 Mar; 157(3):296-300. PubMed ID: 33502462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Everything old is new again: spironolactone and metformin in the treatment of acne.
    Bergstrom KG
    J Drugs Dermatol; 2010 May; 9(5):569-71. PubMed ID: 20480804
    [No Abstract]   [Full Text] [Related]  

  • 58. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
    Barbieri JS; Choi JK; Mitra N; Margolis DJ
    J Drugs Dermatol; 2018 Jun; 17(6):632-638. PubMed ID: 29879250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris.
    Berardesca E; Gabba P; Ucci G; Borroni G; Rabbiosi G
    Int J Tissue React; 1988; 10(2):115-9. PubMed ID: 2972662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.